CD19 Positive
Oncology·MeSH: Leukemia, Biphenotypic, Acute
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| kur-502 | Athenex, Inc. (ATNX) |
Frequently asked questions
How many drugs are in development for CD19 Positive?
BioSniper tracks 1 drug in development for CD19 Positive across 1 company.
How many clinical trials target CD19 Positive?
There are 1 clinical trial targeting CD19 Positive tracked by BioSniper.
Deep-dive into CD19 Positive
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis